CINECA IRIS Institutional Research Information System

GIORDANO, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.641
EU - Europa 4.338
AS - Asia 2.459
SA - Sud America 105
OC - Oceania 37
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.527
CN - Cina 1.309
IT - Italia 814
IE - Irlanda 595
SE - Svezia 486
UA - Ucraina 439
KR - Corea 431
DE - Germania 407
FR - Francia 387
FI - Finlandia 352
GB - Regno Unito 212
SG - Singapore 202
PL - Polonia 190
VN - Vietnam 134
JP - Giappone 106
CA - Canada 95
NL - Olanda 69
AT - Austria 66
TR - Turchia 58
ES - Italia 54
BE - Belgio 53
RU - Federazione Russa 50
BR - Brasile 42
IN - India 42
PH - Filippine 41
AU - Australia 34
DK - Danimarca 33
AR - Argentina 31
GR - Grecia 31
UZ - Uzbekistan 29
HK - Hong Kong 16
TW - Taiwan 15
CH - Svizzera 14
RO - Romania 14
CO - Colombia 13
NO - Norvegia 13
PT - Portogallo 13
SA - Arabia Saudita 11
TH - Thailandia 11
IR - Iran 10
ID - Indonesia 9
MX - Messico 9
RS - Serbia 9
HR - Croazia 8
SN - Senegal 8
EG - Egitto 7
LB - Libano 7
CZ - Repubblica Ceca 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
TN - Tunisia 5
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
BN - Brunei Darussalam 3
CL - Cile 3
CR - Costa Rica 3
CU - Cuba 3
CY - Cipro 3
HU - Ungheria 3
MU - Mauritius 3
MY - Malesia 3
NZ - Nuova Zelanda 3
VE - Venezuela 3
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
GY - Guiana 2
KE - Kenya 2
LV - Lettonia 2
ME - Montenegro 2
MK - Macedonia 2
PA - Panama 2
PK - Pakistan 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SM - San Marino 2
UG - Uganda 2
UY - Uruguay 2
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
SD - Sudan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.618
Salva come PNG Salva come JPEG
Città #
Chandler 1.067
Beijing 1.010
Dublin 585
Houston 431
Ashburn 281
Fairfield 272
Dearborn 261
Ann Arbor 260
Jacksonville 256
Villeurbanne 233
Wilmington 218
Princeton 208
Medford 201
Nyköping 184
Torino 170
Woodbridge 150
Warsaw 143
Redwood City 131
Singapore 119
Seattle 107
Cambridge 98
Pisa 89
Boston 75
Dong Ket 74
Milan 74
Fremont 68
Vienna 62
New York 52
San Mateo 51
Boardman 45
Toronto 43
Rome 39
Munich 37
Turin 34
Norwalk 33
Tokyo 32
Brussels 31
Istanbul 29
Nanjing 27
Shanghai 27
Washington 27
Hefei 26
Verona 26
Rochester 24
Chicago 22
Falls Church 22
Guangzhou 22
London 22
Helsinki 20
Kunming 20
Los Angeles 19
San Diego 18
Paris 17
Jinan 16
Lachine 16
Buenos Aires 15
Phoenix 15
Pune 15
Silver Spring 15
Chengdu 14
Ottawa 13
Halle 12
Mountain View 12
Taipei 12
Perugia 11
Ankara 10
Fuzhou 10
Gainesville 10
Portland 10
Shenyang 10
Belgrade 9
Buffalo 9
Hangzhou 9
Nanchang 9
Polska 9
São Paulo 9
Zhengzhou 9
Amsterdam 8
Brisbane 8
Genova 8
Las Vegas 8
Leiden 8
Madrid 8
Moscow 8
San Francisco 8
Berlin 7
Copenhagen 7
Edinburgh 7
Hong Kong 7
Osaka 7
Padova 7
Philadelphia 7
Weymouth 7
Alessandria 6
Bogotá 6
Frankfurt am Main 6
Fukuoka 6
Gumyojicho 6
Munro 6
State College 6
Totale 8.033
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 467
QUALITY-OF-LIFE IN EUROPEAN PATIENTS WITH ADDISON'S DISEASE; VALIDITY OF THE DISEASE-SPECIFIC QUESTIONNAIRE 408
Glucose metabolism in patients with subclinical Cushing's syndrome. 358
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) 353
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 334
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 284
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE 283
AUTOANTIBODY RESPONSE AGAINST NALP5/MATER IN PRIMARY OVARIAN INSUFFICIENCY AND IN AUTOIMMUNE ADDISON’S DISEASE 261
Do glucocorticoids induce addiction in humans? 255
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 243
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 226
AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL-DYSTROPHY (APECED) IN SICILY: CONFIRMATION THAT R203X IS THE PECULIAR AIRE GENE MUTATION 219
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. 198
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 194
USEFULNESS OF AN AD HOC QUESTIONNAIRE (ACRO-CQ) FOR THE SYSTEMATIC ASSESSMENT OF ACROMEGALY COMORBIDITIES AT DIAGNOSIS AND THEIR MANAGEMENT AT FOLLOW-UP 185
MOLECULAR BACKGROUND AND GENOTYPE-PHENOTYPE CORRELATION IN APECED PATIENTS FROM CAMPANIA AND IN THEIR RELATIVES 177
IDENTIFICATION OF RISK CONDITIONS FOR THE DEVELOPMENT OF ADRENAL DISORDERS: HOW OPTIMIZED PUBMED SEARCH STRATEGIES MAKES THE DIFFERENCE 170
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 165
Endocrine Autoimmunity in Down's Syndrome 152
Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. 139
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 133
Benzodiazepines and anterior pituitary function. 110
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS 107
Secondary adrenal insufficiency: Where is it hidden and what does it look like? 105
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 105
EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM 103
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 96
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE 96
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease. 95
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 94
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 94
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 93
Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing’s disease 91
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 91
Testing pituitary function in aging individuals 91
Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. 90
GHRH and GH secretagogues: clinical perspectives and safety 85
Ageing, growth hormone and physical performance. 84
Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome 81
Biologic activities of growth hormone secretagogues in humans. 79
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. 79
DIFFERENT ENDOCRINE-METABOLIC ABNORMALITIES BETWEEN “PURE” 45,XO TURNER’S SYNDROME AND MOSAICS 79
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 79
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 79
Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease. 79
SENSITIVITY AND SPECIFICITY OF DIFFERENT PROVOCATIVE TESTS ASSESSING THE FUNCTION OF HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS SUSPECTED FOR SECONDARY HYPOADRENALISM 78
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 76
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 76
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 76
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 75
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 73
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS 73
ADULT PATIENTS WITH DOWN’S SYNDROME SHOW ENHANCED BASAL TSH LEVELS BUT NORMAL TSH RESPONSE TO TRH 73
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 73
HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS 72
CORTICOTROPH AND ADRENAL RESPONSIVENESS TO hCRH, HEXARELIN AND ACTH IN YOUNG AND ELDERLY SUBJECTS 71
EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM 71
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE 71
FEMALE PATIENTS WITH DOWN SYNDROME (DS) SHOW A GREATER INSULIN RESISTANCE IN COMPARISON WITH NORMAL FEMALES (NF) 71
A Study of the serotoninergic tone in Healthy subjects and diabetic patients treated by a clinical-paedagogic approach (Group Care) or traditional care. 70
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. 68
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 68
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 68
Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa 67
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 67
TYR-ALA-HEXARELIN, A SYNTHETIC OCTAPEPTIDE, HAS THE SAME ENDOCRINE ACTIVITIES OF HEXARELIN AND GHRP-2 IN HUMANS 67
L-Arginine 65
Ghrelin and synthetic GH secretagogues. 65
EFFECT OF SHORT TERM ADMINISTRATION OF LOW RHGH DOSE ON IGF-I LEVELS AS FUNCTION OF SEX, AGE AND PATHOPHYSIOLOGICAL CONDITIONS 65
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 65
Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade 64
Endocrine function is altered in chronic migraine patients with medication-overuse 64
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 64
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 63
ENDOCRINE DISORDERS 63
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 63
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 63
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 63
PATIENTS WITH DOWN’S SYNDROME (DS) ARE INSULIN RESISTANT INDEPENDENTLY OF BODY MASS INDEX (BMI) 62
SHOULD ALL PATIENTS WITH ADRENAL INSUFFICIENCY OR A SUBGROUP OF PATIENTS WITH PREDIABETES BE TREATED WITH DUAL-RELEASE HYDROCORTISONE? 62
EFFECTS OF ALPRAZOLAM, A BENZODIAZEPINE, ON THE GH, ACTH, CORTISOL AND CATECHOLAMINE RESPONSES TO INSULIN-INDUCED HYPOGLYCEMIA IN HUMANS 62
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 61
The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa 61
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 61
Reference ranges of late-night salivary cortisol and cortisone measured by LC–MS/MS and accuracy for the diagnosis of Cushing’s syndrome 61
Free fatty acids exert an inhibitory effect on ACTH and cortisol secretion in humans 60
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 60
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 59
ACTH-RELEASING EFFECTS OF HEXARELIN, A PEPTIDYL GH SECRETAGOGUE, IN NORMAL SUBJECTS PRETREATED WITH METYRAPONE OR RU486, A GLUCOCORTICOID RECEPTOR ANTAGONIST, AND IN PATIENTS WITH ADDISON'S DISEASE 59
EFFECT OF FREE FATTY ACIDS ON ACTH AND CORTISOL SECRETION IN ANOREXIA NERVOSA 59
PATIENTS WITH AUTOIMMUNE POLYGLANDULAR SYNDROME SHOW REDUCED ADRENAL SENSITIVITY OF CORTISOL, DHEA AND ALDOSTERONE TO THE STIMULATORY EFFECT OF ACTH 1-24 59
Growth hormone treatment in human ageing: benefits and risks 58
MINERALCORTICOID RECEPTOR ANTAGONISTS AS A NEW TOOL TO INVESTIGATE THE HPA AXIS IN HUMANS 58
YOUNG ADULTS WITH DOWN'S SYNDROME SHOW INCREASED CORTICOTROPE RESPONSIVENESS TO hCRH OR HEXARELIN, A PEPTIDYL GH SECRETAGOGUE 58
EFFECT OF HEXARELIN, A SYNTHETIC GHRP, AND/OR hCRH ON ACTH- AND CORTISOL SECRETION IN NORMAL SUBJECTS AND IN PATIENTS WITH CUSHING’S SYNDROME 58
Evaluation on the aire gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy (Apeced) and in their relatives 58
PATIENTS WITH AUTOIMMUNE DISEASES SHOW IMPAIRED ADRENAL SENSITIVITY TO ACTH 1-24 BUT ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 58
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. 57
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 57
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 57
Totale 10.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.295
article - articoli 0
book - libri 0
conference - conferenze 12.296
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.591
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.071 90 74 107 225 143 426 274 165 187 169 143 68
2020/20211.561 188 109 93 69 196 48 136 139 140 147 107 189
2021/20221.670 35 47 54 104 83 70 160 95 72 152 341 457
2022/20232.895 320 255 92 308 246 724 207 194 292 75 121 61
2023/20241.259 160 210 76 79 77 182 50 60 30 58 91 186
2024/202541 41 0 0 0 0 0 0 0 0 0 0 0
Totale 14.184